Westbury Group LLC

The investment bank for enterprises

Business Owner? Request a Contact

Current Engagements

Deal type ID Sector Description Location Comment Key data
M&A Sellside 1834 Business Services Logistics SaaS Company/Project Quarry US "Quarry" is a leader in its segment, with multiple product offerings, attractive historical growth, and the opportunity to accelerate that growth through pricing, new product introductions and entry into adjacent segments. Revs 2021F $12M EBITDA 2021F $3M
Capital Raise Equity 1822 Healthcare Pharmaceutical Company/Project Forest Northeast Crossover financing for patented erectile dysfunction therapeutic approved for sale in Europe; funding for marketing and FDA 505(b)2 pathway. $7 billion market; projecting $700M in sales by 2025
Capital Raise Equity 1785 Natural Resources Water Environmental Technologies & Solutions/Project Firstie Northeast Deploying proven, cost-effective solutions at the intersection of wastewater, resource recovery and renewable energy efficiency. Excellent management, rapid growth, proactive organic & inorganic strategic initiatives.
Capital Raise Equity 1795 Healthcare Drug Delivery Medical Device/Project Speedy Northeast Ultrasonic drug delivery medical device enabling proven drugs to address new indications. Funding 2-3 year expected 505(b)2 regulatory/clinical pathway. Initial focus - repurposing proven antibiotics to address complex infected wounds. Demonstrated 100% success rate in 160+ pre-clinical patient procedures. No adverse effects. 20 limbs saved from amputation.
Capital Raise Equity 1779 Healthcare Trauma Therapeutic/Project Turret Northeast Infusible oxygen carrier for field treatment of hemorrhagic shock. $10M in US Army funding to date.
Capital Raise Equity 1778 Healthcare Telemedicine Platform/Project Saturn Southwest Telemedicine software platform deployed by global insurance providers. 5 million people covered by the platform.
Capital Raise Equity 1774 Healthcare Wound Healing Therapeutic/Project Tamiami South Anhydrous treatment for chronic wounds that stimulates stem cells and increases blood supply for tissue regeneration. Delivery is enabled by telemedicine platform. Marquee board and management team (J&J, P&G, Wyeth)
M&A Sellside 1761 Natural Resources Specialty Chemicals: Super High Purity Alumina/Project Cavitate Northeast Proprietary ultrasonic/chemical technological process with disruptive economic & environmental benefits. Converts commodity aluminum into high-value high purity alumina (critical material to make synthetic sapphire). Economic value in hydrogen by-product. Demonstrated production. End markets include semiconductors, Li-ion batteries, LEDs, biomedical and electronics devices.
M&A Sellside 1758 Healthcare Chain of Body Contouring/Liposuction Centers/Project Belvedere West Thriving chain of body contouring/liposuction centers in high potential markets. 100% private pay. Fees collected in advance. TTM Adj. EBITDA = $11.2M 2021F EBITDA = $15.3M
Capital Raise Debt 1717 Technology / Media / Telecom Telecommunications Software Developer/Project LaSalle Midwest Company embeds software on phones to provide useful information about callers and to block spam and deliver marketing medium for businesses. Partnered with Qualcomm
M&A Sellside 1615 Technology / Media / Telecom Multi-Dwelling Unit Broadband Provider/Project Bandwidth Midwest Provider of broadband and cable to multi-dwelling units across six states in the Midwest. Contract with building owners, not end users. Some bulk. Low churn. Long term contracts. 2020 Adj. EBITDA = $1.4M 9,200 passings, 8,700 RGUs $52.57 ARPU
Capital Raise Equity 1605 Healthcare Semiconductor and Electronics Manufacturer/Project Milliard Midwest Advanced product authentication technology for logistics and anti-counterfeiting measures. Compatible with blockchain and Internet of Things. Potential for EBITDA > $100M over the next several years